schedule i reclassification impact
7 Vermont Dispensaries Secure $15M in Cannabis Benefits Funding
Yes, the seven Vermont dispensaries that landed the $15 million grant are positioned to channel federal research dollars into local clinical programs. In 2024, the federal rollback of the Schedule-I label opened a $15 million pipeline for controlled-substance research, and Vermont’s medical cannabis leaders were among the first to